Focus article

Implementation of primary angioplasty in Europe: Stent for Life initiative progress report

EuroIntervention 2012;8:35-42. DOI: 10.4244/EIJV8I1A7

Steen Dalby Kristensen1*, MD, DMSc; Jean Fajadet2, MD; Carlo Di Mario3, MD; Zuzana Kaifoszova4, MD; Kristina Grønborg Laut1, MPH; Dan Deleanu5, MD; Martine Gilard6, MD, PhD; Giulio Guagliumi7, MD; Omer Goktekin8, MD; Julia Jorgova9, MD, PhD, FESC, FACC; John Kanakakis10, MD; Miodrag Ostojic11, MD, PhD, FESC, FACC, FSCAI; Helder Pereira12, MD, FESC, FACC, FSCAI; Manel Sabate13, MD, PhD; Mohamed Sobhy14, MD, FACC, FESC; Christiaan Vrints15, MD, PhD; William Wijns16, MD, PhD; Petr Widims

1. Department of Cardiology, Aarhus University Hospital, Skejby, Denmark; 2. Clinique Pasteur, Toulouse, France; 3. Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom; 4. Stent for Life Initiative,

Aims: Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial inf

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

stent for life initiativeprimary percutaneous coronary interventionacute st-elevation myocardial infarctionlocal initiativeslocal variation

Share on Facebook Share on Twitter Share on Linkedin